PORTLAND, Ore.--(BUSINESS WIRE)--Calypte Biomedical Corporation (OTCBB: CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, announced today that it will hold a conference call for the investment community on Thursday, April 17, 2008 at 10:30 a.m. EDT to discuss a significant international development.
